Explore
Kailera Therapeutics, Inc. Common StockKLRA
$11.62-1.61%24H
KLRA / USDNASDAQ
Use arrow keys to change the interval
Equity Info
P/E Ratio—
Market Cap$1.86B
EPS-4.16
52 Week Range$9.76 - $28.23
Volume$6.02M
Liquidity Score—
About Kailera Therapeutics, Inc. Common Stock

Kailera Therapeutics, Inc. is a cutting-edge biotechnology company dedicated to developing innovative gene therapies for rare genetic diseases, addressing critical unmet medical needs. Utilizing its proprietary platform, Kailera aims to enhance the precision and effectiveness of therapeutic interventions across various genetic disorders. Backed by a strong intellectual property portfolio and strategic collaborations with premier research institutions, the company is poised to emerge as a leader in the gene therapy sector. As it progresses with a promising pipeline of products, Kailera Therapeutics is committed to delivering long-term value for its investors while significantly improving patient outcomes.

HeadquartersWALTHAM, MA

Buy

—
—

Assets

Asset
Kailera Therapeutics
rKLRA
Reality Finance
Trending
NVDA
NVIDIA Corporation
$151.900.69%
Details
QQQ
Invesco QQQ Trust Series 1
$668.631.37%
Details
MU
Micron Technology Inc
$718.401.90%
Details

Help